{"id":740108,"date":"2023-03-14T18:05:49","date_gmt":"2023-03-14T22:05:49","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/"},"modified":"2023-03-14T18:05:49","modified_gmt":"2023-03-14T22:05:49","slug":"crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/","title":{"rendered":"CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ZUG, Switzerland and BOSTON, March  14, 2023  (GLOBE NEWSWIRE) &#8212; CRISPR Therapeutics\u00a0(Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced an oral presentation of preclinical data at the American Association for Cancer Research (AACR) 2023 Annual Meeting, taking place April 14 \u2013 19, 2023, in Orlando, FL.<\/p>\n<p align=\"justify\">\n        <strong>Title<\/strong>: CTX112 and CTX131: Next-generation CRISPR\/Cas9-engineered allogeneic (allo) CAR T cells incorporating novel edits that increase potency and efficacy in the treatment of lymphoid and solid tumors<br \/><strong>Session Type: <\/strong>Drug Development Special Track Session<br \/><strong>Session Title: <\/strong>New Drugs on the Horizon: Part 1<br \/><strong>Location:<\/strong> Tangerine Ballroom 2, Convention Center<br \/><strong>Date and Time<\/strong>: April 16, 2023, 1:25 \u2013 1:40 p.m. ET<\/p>\n<p align=\"justify\">The data are embargoed until the beginning of the Drug Development Special Track Session: New Drugs on the Horizon: Part 1 at 1:00 p.m. ET on April 16, 2023. A copy of the presentation will be available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DKwf6Ef_NZv2MR0_VUb_1t7oXL2UuTHFtFMFwXlPU74gqje78KBJZzHkq2y6LE3Etd5_45zwvb0nFrwk7ibNhA==\" rel=\"nofollow noopener\" target=\"_blank\">www.crisprtx.com<\/a> once the presentation concludes.<\/p>\n<p align=\"justify\">\n        <strong>About\u00a0CRISPR Therapeutics<\/strong><br \/>\n        <br \/>CRISPR Therapeutics\u00a0is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR\/Cas9 platform. CRISPR\/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA.\u00a0CRISPR Therapeutics\u00a0has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts,\u00a0CRISPR Therapeutics\u00a0has established strategic partnerships with leading companies including\u00a0Bayer, Vertex Pharmaceuticals\u00a0and\u00a0ViaCyte, Inc.\u00a0CRISPR Therapeutics AG\u00a0is headquartered in\u00a0Zug,\u00a0Switzerland, with its wholly-owned\u00a0U.S.\u00a0subsidiary,\u00a0CRISPR Therapeutics, Inc., and R&amp;D operations based in\u00a0Boston, Massachusetts\u00a0and\u00a0San Francisco,\u00a0California, and business offices in\u00a0London,\u00a0United Kingdom. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DKwf6Ef_NZv2MR0_VUb_1imzcKhdOy4d9T8VsBeNAcM2L1N8YSwX1N06dcwYs8fmDMo8k0ADb4qLz5OrAHujBSKowgY_lSxQV-rwPe52dDrqUNNWifCyTIKnWlXG4S6-3zoB5ygMgwBqxuC9RQ7MuzFIcsrgBiYy5LsVFwNSlKpYvLnwVAQplAXxUCavKllA3rSZCM7YKmyz-8hLQJq6H-LB4d7NsJpOKFAEKTZGa1w=\" rel=\"nofollow noopener\" target=\"_blank\">www.crisprtx.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Susan Kim<br \/>+1-617-307-7503<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=b8aceFg41y-OCzLXJDQqu6B-riRTbGj8ARX_IQt8IAhGgoT_Kzl0r7xnrdY5g6lyAE5aJYxGc1Dkff5Uw9NVjR2qm2CHYlRzlVw0e3_eTVK4kpqeyAhEuwXR0irV7ShTf-PVZiDlSE70jQpK2Ee5t8fionu-Hzup26tv7RcH3TBuQcAtB053cmq41YMwq3Q0rODu1mOAl1eagNNlcSLbSYmN7jl3JdEDa9L-37dNBq05l_4X9Z0WDp0nUgakoYHSQMF8xAQhy7VtLwpGdqWb_w==\" rel=\"nofollow noopener\" target=\"_blank\">susan.kim@crisprtx.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Rachel Eides<br \/>+1-617-315-4493<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tGa2RZhINwFE-912-hBniEo2lD_hXiVWgud26XOcDZDzcpc5jibQYwGDGb9bVfVsm-5XbEMIoKkZ1JONHgVoDJ-e5PmZ2syp3u_W1DuJck4=\" rel=\"nofollow noopener\" target=\"_blank\">rachel.eides@crisprtx.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQ0NCM1NDYxOTE5IzIwNDk5MTE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NjI0MDUwMDMtNTI2NS00MDA1LTkwYTctNmZlZDU5MjIwMzZiLTEwNjE0ODI=\/tiny\/CRISPR-Therapeutics-AG.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) &#8212; CRISPR Therapeutics\u00a0(Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced an oral presentation of preclinical data at the American Association for Cancer Research (AACR) 2023 Annual Meeting, taking place April 14 \u2013 19, 2023, in Orlando, FL. Title: CTX112 and CTX131: Next-generation CRISPR\/Cas9-engineered allogeneic (allo) CAR T cells incorporating novel edits that increase potency and efficacy in the treatment of lymphoid and solid tumorsSession Type: Drug Development Special Track SessionSession Title: New Drugs on the Horizon: Part 1Location: Tangerine Ballroom 2, Convention CenterDate and Time: April 16, 2023, 1:25 \u2013 1:40 p.m. ET The data are embargoed until the beginning of the Drug &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-740108","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) &#8212; CRISPR Therapeutics\u00a0(Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced an oral presentation of preclinical data at the American Association for Cancer Research (AACR) 2023 Annual Meeting, taking place April 14 \u2013 19, 2023, in Orlando, FL. Title: CTX112 and CTX131: Next-generation CRISPR\/Cas9-engineered allogeneic (allo) CAR T cells incorporating novel edits that increase potency and efficacy in the treatment of lymphoid and solid tumorsSession Type: Drug Development Special Track SessionSession Title: New Drugs on the Horizon: Part 1Location: Tangerine Ballroom 2, Convention CenterDate and Time: April 16, 2023, 1:25 \u2013 1:40 p.m. ET The data are embargoed until the beginning of the Drug &hellip; Continue reading &quot;CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-14T22:05:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQ0NCM1NDYxOTE5IzIwNDk5MTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting\",\"datePublished\":\"2023-03-14T22:05:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\\\/\"},\"wordCount\":315,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4ODQ0NCM1NDYxOTE5IzIwNDk5MTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\\\/\",\"name\":\"CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4ODQ0NCM1NDYxOTE5IzIwNDk5MTE=\",\"datePublished\":\"2023-03-14T22:05:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4ODQ0NCM1NDYxOTE5IzIwNDk5MTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4ODQ0NCM1NDYxOTE5IzIwNDk5MTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting - Market Newsdesk","og_description":"ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) &#8212; CRISPR Therapeutics\u00a0(Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced an oral presentation of preclinical data at the American Association for Cancer Research (AACR) 2023 Annual Meeting, taking place April 14 \u2013 19, 2023, in Orlando, FL. Title: CTX112 and CTX131: Next-generation CRISPR\/Cas9-engineered allogeneic (allo) CAR T cells incorporating novel edits that increase potency and efficacy in the treatment of lymphoid and solid tumorsSession Type: Drug Development Special Track SessionSession Title: New Drugs on the Horizon: Part 1Location: Tangerine Ballroom 2, Convention CenterDate and Time: April 16, 2023, 1:25 \u2013 1:40 p.m. ET The data are embargoed until the beginning of the Drug &hellip; Continue reading \"CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-14T22:05:49+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQ0NCM1NDYxOTE5IzIwNDk5MTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting","datePublished":"2023-03-14T22:05:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/"},"wordCount":315,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQ0NCM1NDYxOTE5IzIwNDk5MTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/","name":"CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQ0NCM1NDYxOTE5IzIwNDk5MTE=","datePublished":"2023-03-14T22:05:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQ0NCM1NDYxOTE5IzIwNDk5MTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQ0NCM1NDYxOTE5IzIwNDk5MTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=740108"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740108\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=740108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=740108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=740108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}